12:00 AM
 | 
Jul 12, 2010
 |  BioCentury  |  Finance

Google's Game-Changer

Google Ventures leads $22M round for stem cell play iPierian
Google's game-changer

Although Google Ventures' second life science investment is a much earlier round than its first, the firm maintains the theme is the same - game changing companies.

Last October, Google Ventures led an undisclosed series D round in human antibody company Adimab Inc.

This time, Google Ventures led a $22 million series B round in induced pluripotent stem cell company iPierian Inc. New investors Mitsubishi UFJ Capital and ATEL Ventures joined all of iPierian's existing investors: Kleiner Perkins Caufield &...

Read the full 393 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >